JYNARQUE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc.. The primary component is Tolvaptan.
Product ID | 59148-083_1c7d17da-0b48-425b-949a-6f90bfd3a71c |
NDC | 59148-083 |
Product Type | Human Prescription Drug |
Proprietary Name | JYNARQUE |
Generic Name | Tolvaptan |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-04-23 |
Marketing Category | NDA / NDA |
Application Number | NDA204441 |
Labeler Name | Otsuka America Pharmaceutical, Inc. |
Substance Name | TOLVAPTAN |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Vasopressin V2 Receptor Antagonist [EPC],Vasopressin V2 Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2018-04-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204441 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-04-23 |
Ingredient | Strength |
---|---|
TOLVAPTAN | 30 mg/1 |
SPL SET ID: | 3febc0a1-9e5a-4ce0-843d-210f21d862c4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59148-079 | Jynarque | tolvaptan |
59148-080 | Jynarque | tolvaptan |
59148-082 | JYNARQUE | tolvaptan |
59148-083 | JYNARQUE | tolvaptan |
59148-087 | Jynarque | tolvaptan |
59148-088 | Jynarque | tolvaptan |
59148-089 | Jynarque | Jynarque |
59148-020 | SAMSCA | tolvaptan |
59148-021 | SAMSCA | tolvaptan |
31722-868 | Tolvaptan | Tolvaptan |
31722-869 | Tolvaptan | Tolvaptan |
49884-768 | Tolvaptan | Tolvaptan |
49884-770 | Tolvaptan | Tolvaptan |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JYNARQUE 87632640 5482786 Live/Registered |
Otsuka Pharmaceutical Co., Ltd. 2017-10-03 |